Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Calcitriol × Clear all

NCT00273338 2007-11-06

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Phase 3 Terminated

Prostatic Neoplasms